De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning

The global pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) created a rush to discover drug candidates. Despite the efforts, so far no vaccine or drug has been approved for treatment. Artificial intelligence offers solutions that could...

Descripción completa

Detalles Bibliográficos
Autores principales: Santana, Marcos V. S., Silva-Jr, Floriano P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852053/
https://www.ncbi.nlm.nih.gov/pubmed/33531083
http://dx.doi.org/10.1186/s13065-021-00737-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852053/
https://www.ncbi.nlm.nih.gov/pubmed/33531083
http://dx.doi.org/10.1186/s13065-021-00737-2

Ejemplares similares